[go: up one dir, main page]

DK153587D0 - RELATIONSHIPS WITH NOOTROP EFFECTS, AGENTS CONTAINING THESE AND THEIR USE IN TREATMENT OF PREVENTION OF COGNITIVE DYSFUNCTIONS - Google Patents

RELATIONSHIPS WITH NOOTROP EFFECTS, AGENTS CONTAINING THESE AND THEIR USE IN TREATMENT OF PREVENTION OF COGNITIVE DYSFUNCTIONS

Info

Publication number
DK153587D0
DK153587D0 DK153587A DK153587A DK153587D0 DK 153587 D0 DK153587 D0 DK 153587D0 DK 153587 A DK153587 A DK 153587A DK 153587 A DK153587 A DK 153587A DK 153587 D0 DK153587 D0 DK 153587D0
Authority
DK
Denmark
Prior art keywords
treatment
nootrop
relationships
prevention
effects
Prior art date
Application number
DK153587A
Other languages
Danish (da)
Other versions
DK172221B1 (en
DK153587A (en
Inventor
Franz Hock
Josef Scholtholt
Hansjoerg Urbach
Reiner Henning
Ulrich Lerch
Wolf-Ulrich Nickel
Wolfgang Rueger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK153587D0 publication Critical patent/DK153587D0/en
Publication of DK153587A publication Critical patent/DK153587A/en
Application granted granted Critical
Publication of DK172221B1 publication Critical patent/DK172221B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Epoxy Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention relates to novel compounds having a nootropic activity, the use of ACE inhibitors as medicaments having nootropic activity, agents containing them, and their use in the treatment and prophylaxis of cognitive malfunctions.
DK153587A 1986-03-27 1987-03-26 Use of ACE Inhibitors or their Physiologically Acceptable Salts for the Preparation of Nootropic Drugs DK172221B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (en) 1986-03-27 1986-03-27 COMPOUNDS WITH NOOTROPPER ACTION, THESE CONTAINERS AND THEIR USE IN THE TREATMENT AND PROPHYLAXIS OF COGNITIVE DYSFUNCTIONS
DE3610391 1986-03-27

Publications (3)

Publication Number Publication Date
DK153587D0 true DK153587D0 (en) 1987-03-26
DK153587A DK153587A (en) 1987-09-28
DK172221B1 DK172221B1 (en) 1998-01-12

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK153587A DK172221B1 (en) 1986-03-27 1987-03-26 Use of ACE Inhibitors or their Physiologically Acceptable Salts for the Preparation of Nootropic Drugs

Country Status (25)

Country Link
EP (1) EP0243645B1 (en)
JP (1) JPS62240698A (en)
KR (1) KR870008841A (en)
CN (1) CN1031267C (en)
AT (1) ATE102954T1 (en)
AU (1) AU621278B2 (en)
CA (1) CA1341064C (en)
CS (2) CS276179B6 (en)
DD (1) DD280765A5 (en)
DE (2) DE3610391A1 (en)
DK (1) DK172221B1 (en)
EG (1) EG18175A (en)
ES (1) ES2061447T3 (en)
FI (1) FI91876C (en)
HU (2) HU203117B (en)
IE (1) IE62456B1 (en)
MA (1) MA20919A1 (en)
NO (1) NO178546C (en)
NZ (1) NZ219764A (en)
OA (1) OA08506A (en)
PH (1) PH27210A (en)
PT (1) PT84564B (en)
RU (1) RU1836335C (en)
TN (1) TNSN87045A1 (en)
ZA (1) ZA872230B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA1321753C (en) * 1987-04-27 1993-08-31 Abraham Sudilovsky Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (en) * 1987-09-16 1989-04-06 Hoechst Ag NEW AMINO ACID ESTERS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
DE3739690A1 (en) * 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
DE3801587A1 (en) * 1988-01-21 1989-08-03 Hoechst Ag NEW AMINO ACID GLYCERIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
EP0331609A3 (en) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin converting enzyme inhibitors having psychotropic effects
DE3803225A1 (en) * 1988-02-04 1989-08-17 Hoechst Ag AMINO ACID AMIDE WITH PSYCHOTROPIC EFFECT, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING THE SAME AND THEIR USE
JPH01275529A (en) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc Suppressing treatment agent of delayed motion effect
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
EP1372620A2 (en) * 2001-03-15 2004-01-02 Saegis Pharmaceuticals Methods for restoring cognitive function following systemic stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88621I2 (en) * 1980-10-23 1995-09-01 Schering Corp Sandopril
DE3300774A1 (en) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CS212687A3 (en) 1992-04-15
NO178546B (en) 1996-01-08
MA20919A1 (en) 1987-10-01
FI91876B (en) 1994-05-13
IE62456B1 (en) 1995-02-08
PT84564A (en) 1987-04-01
HU203117B (en) 1991-05-28
CN1031267C (en) 1996-03-13
FI871304A0 (en) 1987-03-25
EP0243645B1 (en) 1994-03-16
ATE102954T1 (en) 1994-04-15
CN87102304A (en) 1987-12-30
FI91876C (en) 1994-08-25
OA08506A (en) 1988-07-29
PH27210A (en) 1993-05-04
JPS62240698A (en) 1987-10-21
EP0243645A3 (en) 1990-01-24
AU7064987A (en) 1987-10-01
HU202118B (en) 1991-02-28
AU621278B2 (en) 1992-03-12
KR870008841A (en) 1987-10-21
CS276179B6 (en) 1992-04-15
NO871282L (en) 1987-09-28
ZA872230B (en) 1987-09-21
TNSN87045A1 (en) 1990-01-01
RU1836335C (en) 1993-08-23
EG18175A (en) 1994-07-30
IE870784L (en) 1987-09-27
DK172221B1 (en) 1998-01-12
PT84564B (en) 1989-11-10
CS276385B6 (en) 1992-05-13
DE3789330D1 (en) 1994-04-21
DE3610391A1 (en) 1987-10-08
EP0243645A2 (en) 1987-11-04
NZ219764A (en) 1990-11-27
ES2061447T3 (en) 1994-12-16
HUT46046A (en) 1988-09-28
FI871304A7 (en) 1987-09-28
CA1341064C (en) 2000-08-01
HU896609D0 (en) 1990-02-28
CS651989A3 (en) 1992-05-13
NO871282D0 (en) 1987-03-26
DD280765A5 (en) 1990-07-18
DK153587A (en) 1987-09-28
NO178546C (en) 1996-04-17

Similar Documents

Publication Publication Date Title
DK153587D0 (en) RELATIONSHIPS WITH NOOTROP EFFECTS, AGENTS CONTAINING THESE AND THEIR USE IN TREATMENT OF PREVENTION OF COGNITIVE DYSFUNCTIONS
FI882742A7 (en) Treatment agents and compositions containing them.
DK0735890T3 (en) Mixtures of 2 ', 3'-dideoxyinosine and hydroxycarbamide to inhibit retroviral spread
HU9301445D0 (en) Inhibitors of retrovirus protease
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
DK472688A (en) USE OF BEZAFIBRATE TO TREAT DIABETES
ATE71840T1 (en) VIRUS INHIBITING NUCLEOSIDE MIXTURE.
DK116087D0 (en) 2-UREETEROCYCLYLMETHYLSULPHINYLATEHIENOIMIDAZOLE COMPOUNDS AND THEIR USE AS ANTIULCUS AGENTS
FI851365A0 (en) LIPOSOMER MED INHALERBARA ALLERGENER FOER BEHANDLING AV ALLERGENER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE CEEKEMEDEL.
DK24687A (en) 3-ALKOXYFLAVON DERIVATIVES AND ANTIVIRALLY EFFECTIVE THERAPEUTIC AGENTS CONTAINING THESE
ATA120686A (en) WOOD TREATMENT CHAMBER
DE3674997D1 (en) WOOD TREATMENT COMPOSITION.
DE3868051D1 (en) POTENTIALIZING THE ANTI-HYPERTENSIVE EFFECT OF ACE INHIBITORS.
AT388001B (en) ANNEX TO REMOVAL OF TRACK YOCKS
FI871737A0 (en) TREATMENT OF MEASURES IN THE FLUIDISERAD BAEDD.
JO1516B1 (en) Compounds having a congnition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions
DK332786D0 (en) USE OF 1,4-DIHYDROPYRIDINE DERIVATIVES AND COMBINATIONS THEREOF WITH CALCITONINES
ATE57458T1 (en) WOOD TREATMENT COMPOSITION.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired